Benzinga's Top Pre-Market NASDAQ Losers (AMAG, GXDX, CHBT, TCAP)
Posted in: News, Short Ideas, Offerings, Pre-Market Outlook, Intraday Update, Markets, Trading Ideas
AMAG Pharmaceuticals Inc (NASDAQ: AMAG) dipped 11.03% to $20.90 in the pre-market session. AMAG's trailing-twelve-month operating margin is -182.31%.
Genoptix Inc (NASDAQ: GXDX) lost 10.31% to $14.70 in the pre-market session. GXDX's quarterly earnings dipped 28.80% y/y.
China-Biotics Inc (NASDAQ: CHBT) fell 8.64% to $9.61 in the pre-market session. CHBT has filed 2 new patent applications to the State Bureau of Intellect Property.
Triangle Capital Corporation (NASDAQ: TCAP) slipped 6.03% to $15.75 in the pre-market trading. TCAP has initiated its public offering of 2,000,000 shares of common stock.
Read more from Benzinga's Company news.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
